O'Shaughnessy Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9,792	Closed	-$36K	–	2766
2021 Q3	$36K	Hold	9,792	–	–	﹤0.01%	1775
2021 Q2	$43K	Sell	9,792 -26,078	-73%	-$106K	﹤0.01%	1641
2021 Q1	$147K	Sell	35,870 -50,600	-59%	-$219K	﹤0.01%	1051
2020 Q4	$345K	Buy	86,470 +3,599	+4%	+$11.6K	0.01%	638
2020 Q3	$224K	Hold	82,871	–	–	0.01%	664
2020 Q2	$228K	Sell	82,871 -31,958	-28%	-$89.2K	0.01%	606
2020 Q1	$272K	Buy	114,829 +54,256	+90%	+$185K	0.01%	396
2019 Q4	$284K	Buy	+60,573	New	+$248K	0.01%	528

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

O'Shaughnessy Asset Management's ATRS Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q4 2021, closing a stake of 9,792 shares — an estimated $36K sold.

O'Shaughnessy Asset Management first reported a position in ATRS in Q4 2019 and held it in 8 quarters. The position peaked at $345K in Q4 2020. 162 funds tracked by Wall St. Rank hold ATRS as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining Antares Pharma, Inc. position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 9,792 Antares Pharma, Inc. shares in Q4 2021, an estimated $36K.
O'Shaughnessy Asset Management first reported a position in Antares Pharma, Inc. in Q4 2019 and held it in 8 quarters.
O'Shaughnessy Asset Management's Antares Pharma, Inc. position peaked at $345K in Q4 2020.
162 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.